---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/44473311.md"
description: "$XTALPI(02228.HK) Good news? Or bad news?Anthropic has also entered the drug discovery space. The team behind writing prompts for Claude turns out to be Citrini Research, previously well-known in the semiconductor and AI sectors.- After running for 64 hours, computational power generated 318,000 scorpion venom-binding proteins- 211 candidates were selected; AI drafted emails to place orders with Twist Bioscience for synthesis- Wet lab validation: 17 showed binding capability318,000 designs, 211 advanced to the lab, 17 passed.OpenAI: Acquired Orchestra to act as "project managers" at pharma companies overseeing schedules;Anthropic: Letting AI generate its own questions and place orders directly, while leaving testing to the labs."
datetime: "2026-10-22T01:38:31.000Z"
locales:
  - [en](https://longbridge.com/en/topics/44473311.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/44473311.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/44473311.md)
author: "[Boss's Boss](https://longbridge.com/en/profiles/123.md)"
generator: "portal-rs"
---

# $XTALPI(02228.HK) Good news? Or bad news?Anthropic…


### Related Stocks

- [TWST.US](https://longbridge.com/en/quote/TWST.US.md)
- [02228.HK](https://longbridge.com/en/quote/02228.HK.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**